Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-IMG-155226

Xenbase Image ID: 155226

Figure 2. Effects of Wnt antagonists on Pk3 polarization in the epidermal ectoderm.Embryos were injected with RNAs encoding GFP-Pk3 (150 pg), Xenopus HA-Vangl2 (120 pg), and LacZ (1 ng, A) or DN-Wnt11 (2 ng, B) or Ror2-TM (1 ng, C). (A–C) GFP fluorescence is shown in the epidermal ectoderm of embryos fixed at stage 15. Anterior is to the top. Scale bar, 20 µm. (D) Protein levels of GFP-Pk3 and HA-Vangl2 in the ectoderm analyzed by immunoblotting. A non-specific band detected by anti-HA antibody reflects protein loading.DOI: http://dx.doi.org/10.7554/eLife.16463.004Figure 2—figure supplement 1. ECD8 disrupts Pk3 polarization in the epidermis.Four-cell embryos were injected at the ventral animal location with RNAs encoding GFP-Pk3 (150 pg) and Xenopus HA-Vangl2 (60 pg), followed by injection of RNAs for TurboFP635 (TFP, 1 ng) (B) or the extracellular domain of Frizzled 8 (ECD8, 1 ng) (C) into the dorsal marginal zone. GFP fluorescence in the epidermal ectoderm of stage 15 embryos is shown. Scale bar, 20 µm.DOI: http://dx.doi.org/10.7554/eLife.16463.005

Image published in: Chu CW and Sokol SY (2016)

© 2016, Chu et al. This image is reproduced with permission of the journal and the copyright holder. This is an open-access article distributed under the terms of the Creative Commons Attribution license

Larger Image
Printer Friendly View

Return to previous page